# Rakuten Medical funding rounds and investors

As of 14 Oct 2026, Rakuten Medical has raised $100M across 1 verified round on record; latest: $100 million Series F led by TaiAx Life Science Fund, announced 7 Jan 2026.

Rakuten Medical develops cancer therapies based on the Alluminox® platform, aimed at treating various cancers.

Website: https://rakuten-med.com  
Headquarters: San Diego, United States  
Page: https://fireround.dev/companies/rakuten-med.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-01-07 | Series F | $100 million | TaiAx Life Science Fund | ABIES Capital, Daiwa Securities, Mitsui Sumitomo Insurance, Nexus CVC, OEP Group, Sumitomo Mitsui Banking | [pulse2.com](https://pulse2.com/rakuten-medical-100-million-series-f) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.